Marketing-authorisation holder · United States
Nexus
10 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
10 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| BUSULFAN6mg/ml · Injectable | Busulfan | United States | Marketed | 2015 |
| EMERPHED25mg/5ml (5mg/ml) | 50mg/10ml (5mg/ml) · Solution | Ephedrine | United States | Marketed | 2020 |
| FLUORESCEIN SODIUM500mg base/2ml (eq 250mg base/ml) | 500mg base/5ml (eq 100mg base/ml) · Injectable | Fluorescein | United States | Marketed | 2023 |
| MINOCYCLINE HYDROCHLORIDE100mg base/vial · Injectable | Minocycline | United States | Marketed | 2025 |
| POTASSIUM CHLORIDE 10MEQ14.9mg/ml | 745mg/100ml | 746mg/100ml · Injectable | Potassium chloride | United States | Marketed | 2020 |
| POTASSIUM CHLORIDE 20MEQ1.49gm/100ml | 29.8mg/ml · Injectable | Potassium chloride | United States | Marketed | 2020 |
| POTASSIUM CHLORIDE 40MEQ2.98gm/100ml · Injectable | Potassium chloride | United States | Marketed | 2020 |
| TACROLIMUS5mg base/ml · Injectable | Tacrolimus | United States | Marketed | 2017 |
| TIROFIBAN HYDROCHLORIDE12.5mg base/250ml (eq 0.05mg base/ml) | 5mg base/100ml (eq 0.05mg base/ml) · Solution | Tirofiban | United States | Marketed | 2021 |
| TRANEXAMIC ACID1gm/100ml (10mg/ml) · Solution | Tranexamic acid | United States | Marketed | 2019 |